Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors
- 1 December 1998
- journal article
- clinical trial
- Published by Elsevier BV in Surgery
- Vol. 124 (6), 1000-1004
- https://doi.org/10.1067/msy.1998.93919
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Treatment of liver metastases in patients with neuroendocrine tumors.Langenbecks Archives Of Surgery, 1998
- Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.Gut, 1996
- Expression of Somatostatin Receptors in Normal, Inflamed, and Neoplastic Human Gastrointestinal TissuesAnnals of the New York Academy of Sciences, 1994
- Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.JCI Insight, 1994
- Molecular biology of somatostatin receptorsTrends in Neurosciences, 1993
- The visualization of gastroenteropancreatic endocrine tumorsMetabolism, 1992
- Inhibitory Effect of the Somatostatin Analogue Octreotide (SMS 201-995) on the Growth of Human and Animal Tumors in Rodent ModelsPublished by S. Karger AG ,1992
- The Use of the Long-Acting Somatostatin Analog Octreotide in the Treatment of Gut Neuroendocrine Tumors*Journal of Clinical Endocrinology & Metabolism, 1991
- Somatostatin-Receptor Imaging in the Localization of Endocrine TumorsNew England Journal of Medicine, 1990
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989